Company / Working Capital per Share
Wave Life Sciences Ltd. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.40
FY2025
5-year range
$0.45 / $3.40
FY2021-FY2025
Trend
+93.2%
vs FY2024
Sector context
#129 of 210
Health Care
What the data says
At $3.40, Wave Life Sciences Ltd.'s working capital per share ranks #129 of 210 in the Health Care sector. Working Capital per Share has increased for 3 consecutive years, from $0.45 in FY2022 to $3.40 in FY2025.
Based on SEC 10-K filings.
3.40 in FY2025 with a 5-year CAGR of +1.4%.
Improved from $0.56 to $3.40 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +95.9%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
#129 of 210 in Health CareTop 61% of 210This company $3.40 Sector average $146.86
▼
-97.7% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 93.2% year-over-year.
- Ranks #129 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.40 | +93.2% |
| FY2024 | $1.76 | +212.2% |
| FY2023 | $0.56 | +24.7% |
| FY2022 | $0.45 | -77.6% |
| FY2021 | $2.02 | -36.5% |
| FY2020 | $3.17 | +39.0% |
| FY2019 | $2.28 | -12.0% |
| FY2018 | $2.60 | -53.9% |
| FY2017 | $5.63 | -13.2% |
| FY2016 | $6.49 | -82.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026